Central Trust Company’s Inspire Medical Systems INSP Stock Holding History

Central Trust Company’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-67	Closed	-$8.7K	–	1466
2025 Q2	$8.7K	Hold	67	–	–	﹤0.01%	1142
2025 Q1	$10.7K	Hold	67	–	–	﹤0.01%	1101
2024 Q4	$12.4K	Hold	67	–	–	﹤0.01%	1068
2024 Q3	$14.1K	Hold	67	–	–	﹤0.01%	1008
2024 Q2	$8.97K	Hold	67	–	–	﹤0.01%	1088
2024 Q1	$14.4K	Hold	67	–	–	﹤0.01%	1020
2023 Q4	$13.6K	Hold	67	–	–	﹤0.01%	1025
2023 Q3	$13.3K	Hold	67	–	–	﹤0.01%	999
2023 Q2	$21.8K	Hold	67	–	–	﹤0.01%	920
2023 Q1	$15.7K	Hold	67	–	–	﹤0.01%	977
2022 Q4	$16.9K	Hold	67	–	–	﹤0.01%	943
2022 Q3	$12K	Sell	67 -2	-3%	-$402	﹤0.01%	1009
2022 Q2	$13K	Hold	69	–	–	﹤0.01%	1005
2022 Q1	$18K	Buy	69 +2	+3%	+$457	﹤0.01%	972
2021 Q4	$15K	Hold	67	–	–	﹤0.01%	994
2021 Q3	$16K	Hold	67	–	–	﹤0.01%	953
2021 Q2	$13K	Buy	+67	New	+$13.3K	﹤0.01%	975

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Central Trust Company's INSP Position: Q3 2025 in Review

Central Trust Company sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 67 shares — an estimated $8.7K sold.

Central Trust Company first reported a position in INSP in Q2 2021 and held it in 17 quarters. The position peaked at $21.8K in Q2 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

Central Trust Company reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
Central Trust Company sold 67 Inspire Medical Systems shares in Q3 2025, an estimated $8.7K.
Central Trust Company first reported a position in Inspire Medical Systems in Q2 2021 and held it in 17 quarters.
Central Trust Company's Inspire Medical Systems position peaked at $21.8K in Q2 2023.
325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Central Trust Company's 13F filing for Q3 2025, filed 6 Nov 2025.